Filing Details
- Accession Number:
- 0001144204-12-000737
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-05 16:48:13
- Reporting Period:
- 2012-01-04
- Filing Date:
- 2012-01-05
- Accepted Time:
- 2012-01-05 16:48:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1318641 | Cleveland Biolabs Inc | CBLI | Services-Commercial Physical & Biological Research (8731) | 200077155 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1523106 | C David Hohn | C/O Cleveland Biolabs, Inc. 73 High Street Buffalo NY 14203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.005 Per Share | Acquisiton | 2012-01-04 | 1,000 | $2.98 | 2,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2011.